Transplantation, Haploidentical
"Transplantation, Haploidentical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals who share a partial haplotype match.
| Descriptor ID |
D000075442
|
| MeSH Number(s) |
E04.936.864.350
|
| Concept/Terms |
Transplantation, Haploidentical- Transplantation, Haploidentical
- Haploidentical Transplantations
- Transplantations, Haploidentical
- Haploidentical Transplantation
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Haploidentical".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Haploidentical".
This graph shows the total number of publications written about "Transplantation, Haploidentical" by people in this website by year, and whether "Transplantation, Haploidentical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 9 | 3 | 12 |
| 2019 | 9 | 2 | 11 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 3 | 3 |
| 2024 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Haploidentical" by people in Profiles.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation. Pediatr Blood Cancer. 2024 Nov; 71(11):e31311.
-
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplant Cell Ther. 2024 Sep; 30(9):909.e1-909.e11.
-
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. J Hematol Oncol. 2024 06 27; 17(1):50.
-
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies. Blood Adv. 2024 06 25; 8(12):3237-3245.
-
Future directions in haploidentical hematopoietic stem cell transplantation. Hematology. 2024 Dec; 29(1):2366718.
-
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplant. 2024 Jul; 59(7):918-927.
-
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy. Front Immunol. 2022; 13:1033871.
-
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study. Haematologica. 2022 10 01; 107(10):2496-2500.
-
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplant Cell Ther. 2022 07; 28(7):395.e1-395.e11.